This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. He is known for his use of sharp humor, which can be seen in his mock documentary about a fictional illness called ‘Motivational Deficiency Disorder.’ This applies in the mental illness world and everywhere in medicine.
R egardless of the context and cause, distress is increasingly interpreted and diagnosed as a mental illnesscommonly clinical depression and/or anxietydisorder. The biomedical approach to distress has spread beyond the health/mentalhealth sector and has seeped into every sector of the community.
I n a previous chapter I reported data from the Centers for Disease Control and Prevention 11c that suicides for the years 2007 to 2017 increased by 30% while the teen rate (ages 10 to 24) increased by 56%! This is the first step in evaluating any new drug, trying out the drug on normal people without the health problem under consideration.
These drugs have often become the sole treatment for a variety of behavioral healthdisorders including clinical depression, anxietydisorders, obsessive compulsive disorder, and other approved and off-label uses of these drugs. Is depression really on the increase?
Moore: We’re here to talk about some of your experiences of the mentalhealth system and polypharmacy, experiences which are beautifully captured in your book, May Cause Side Effects , published by Central Recovery Press in 2022. I’m diagnosing a depressive and anxietydisorder and recommending medication.”
Sugarman has spent decades critically interrogating the ways mainstream psychology reflects and reinforces the ideologies of neoliberalism , shaping how we understand identity, mentalhealth, and human development. One of the strange things about being a professor is that we get older, but our students stay the same age.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content